Urinary CC16 after challenge with dry air hyperpnoea and mannitol in recreational summer athletes  by Kippelen, Pascale et al.
Respiratory Medicine (2013) 107, 1837e1844Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier .com/locate/rmedUrinary CC16 after challenge with dry air
hyperpnoea and mannitol in recreational
summer athletesPascale Kippelen a,*, Ellen Tufvesson b, Leena Ali c,
Leif Bjermer b, Sandra D. Anderson daCentre for Sports Medicine and Human Performance, Brunel University, UB8 3PH Uxbridge,
Middlesex, UK
bDepartment of Respiratory Medicine & Allergology, Lund University, 22 185 Lund, Sweden
cDepartment of Anaesthetics, Ealing Hospital NHS Trust, Uxbridge Road, UB1 3HW Southall, UK
dDepartment of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW
2050, AustraliaReceived 24 June 2013; accepted 21 September 2013
Available online 2 October 2013KEYWORDS
Asthma;
Exercise-induced
bronchoconstriction;
Airway hyper-
responsiveness;
Clara cell;
Club cell;
Epithelial injury* Corresponding author. Tel.: þ44 (0
E-mail address: pascale.kippelen@
0954-6111/$ - see front matter ª 201
http://dx.doi.org/10.1016/j.rmed.201Summary
Airway epithelial injury is regarded as a key contributing factor to the pathogenesis of
exercise-induced bronchoconstriction (EIB) in athletes. The concentration of the pneumopro-
tein club cell (Clara cell) CC16 in urine has been found to be a non-invasive marker for
hyperpnoea-induced airway epithelial perturbation. Exercise-hyperpnoea induces mechanical,
thermal and osmotic stress to the airways. We investigated whether osmotic stress alone
causes airway epithelial perturbation in athletes with suspected EIB. Twenty-four recreational
summer sports athletes who reported respiratory symptoms on exertion performed a standard
eucapnic voluntary hyperpnoea test with dry air and a mannitol test (osmotic challenge) on
separate days. Median urinary CC16 increased from 120 to 310 rg mmol creatinine1 after
dry air hyperpnoea (P Z 0.002) and from 90 to 191 rg mmol creatinine1 after mannitol
(P Z 0.021). There was no difference in urinary CC16 concentration between athletes who
did or did not bronchoconstrict after dry air hyperpnoea or mannitol. We conclude that, in rec-
reational summer sports athletes with respiratory symptoms, osmotic stress per se to the
airway epithelium induces a rise in urinary excretion of CC16. This suggests that hyperosmolar-
ity of the airway surface lining perturbs the airway epithelium in symptomatic athletes.
ª 2013 Elsevier Ltd. All rights reserved.) 1895 267649; fax: þ44 (0) 1895 269769.
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1838 P. Kippelen et al.Introduction Materials and methodsAirway epithelium is the first barrier to the external envi-
ronment and thus crucially important for the protection of
the internal environment. In asthma, disruption of the
epithelial barrier is regarded as one of the primary de-
fects [1]. Through detection of the pneumoprotein club cell
(Clara cell) CC16 in extra-pulmonary fluids, strenuous ex-
ercise has recently been shown to transiently compromise
the integrity of the airway epithelium [2e5].
Exercise-induced bronchoconstriction (EIB) is highly
prevalent in individuals with asthma [6], but can also be
observed in otherwise healthy individuals without any other
features of asthma [7,8]. Endurance athletes are particu-
larly at risk for EIB [9]. In this population, the mechanical
stress imposed on the airways by sustained hyperpnoea
combined with various environmental stimuli could create a
‘chronic wound scenario’, whereby repeated injury and
repair of the airway epithelium leads to airway hyper-
responsiveness (AHR) [10]. Further, during hyperpnoea of
dry air the water lost by evaporation from the airway sur-
face is replaced by water moving from the epithelial cells,
so that the cells become shrunken and hyperosmolar [11].
This change in height and osmolarity in the epithelial cell
also occurs in response to a hyperosmolar challenge to the
airway surface with mannitol [12].
Eucapnic voluntary hyperpnoea (EVH) of dry air is the
recommended bronchial provocation challenge for EIB
detection in elite athletes [13]. In addition to mechanical
stress, EVH causes both thermal and osmotic changes in the
airways. Osmotic challenge with inhaled mannitol has also
been used as a surrogate for exercise to identify EIB
[14,15].
Bronchial provocation challenge with swimming, but not
with mannitol has recently been associated with an in-
crease in urinary CC16 concentration in young elite
swimmers [4]. Further, in another study [5], serum con-
centration of CC16 increased after a 1500 m swimming
session in well-trained young adult swimmers, but not after
recreational pool attendance in children and adults. Taken
together these findings suggest that the increased con-
centration of CC16 in extra-pulmonary fluids following
strenuous exercise may be a consequence of mechanical
stress on the airway epithelium rather than osmotic stress.
Chlorinated by-products found in indoor swimming pools
however have the capacity to disrupt the airway epithelium
acutely [5] and may damage the club cells [16]. Thus there
is uncertainty regarding the respective role of mechanical
stress and of osmotic stress on CC16 response during
exercise-hyperpnoea in non-swimmers.
The aim of our study was to investigate if urinary con-
centration of CC16 increased in response to an osmotic
stimulus in recreational athletes not engaged in competi-
tive swimming. To this end, urinary concentration of CC16
was measured in a group of recreational summer sport
athletes with suspected EIB in two separate conditions: the
first, following a 6-min EVH test, and the second, following
inhalation of dry powder mannitol to cause the same de-
gree of bronchoconstriction as EVH. Based on previous
publications [2,4,17], we proposed that an increase in uri-
nary CC16 will be observed only following EVH.Study population
Twenty-four recreational summer sports athletes who re-
ported respiratory symptoms, such as cough, wheeze,
breathlessness, chest tightness or mucus hyper-secretion,
on exertion were recruited. Twelve of the participants had
a previous physician diagnosis of asthma (two were diag-
nosed with childhood asthma only) and five had a previous
physician diagnosis of EIB. None had had a bronchial prov-
ocation challenge done before. Five participants used
inhaled corticosteroids (ICS) daily for at least 6 months
(dosage: 400e1000 mg beclomethasone daily or equivalent,
including two on combination therapy) and another five
used inhaled short-acting beta2-agonists (SABA) alone. All
participants trained for a minimum of 3 h per week and
most (92%) were taking part in some form of competition
(but none represented their country at international
sporting events). Exclusion criteria were: baseline forced
expiratory volume in the first second (FEV1) <70% pre-
dicted, respiratory infection within the last month, current
smokers, pregnant women, elite athletes and competitive
swimmers. Participants refrained from caffeine or
alcohol-containing-drinks on the test days, and from exer-
cise within 4 h. ICS were withheld for 12 h, SABA for 8 h and
long acting beta2-agonists for 24 h. The study was approved
by Brunel University Research Ethics Committee (RE21-08).
All participants provided informed written consent.
Study design
Participants were asked to attend the laboratory between
08:00 and 09:30 h. They all completed two experimental
visits separated by at least 48 h, but less than 15 days.
During the first visit, an EVH test and a skin prick test were
carried out. During the second visit, a mannitol test was
performed. During both visits urine samples were collected
prior to and after bronchial provocation testing.
Spirometry
Maximal forced vital capacity manoeuvres were carried out
at baseline on a MicroLoop spirometer (MicroMedical, Car-
dinal Health, Basingstoke, UK) according to international
guidelines [18]. Predicted normal values were determined
from established reference values [19].
EVH test
The EVH challenge was performed on a EucapSys (SMTEC
SA, Nyon, Suisse) according to standard recommendations
[20]. Participants were required to breathe at a target
ventilation rate of 30 times baseline FEV1 for 6 min while
breathing in a dry air mixture at room temperature con-
taining approx. 5% CO2, 21% O2 and balance N2. Forced vital
capacity manoeuvres were performed in duplicate at 3, 5,
10, 15, 20, 30 and 60 min after the challenge and the best
FEV1 value was recorded at each time point. A test was
considered positive when a 10% fall in FEV1 from baseline
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The % fall was used as index of reactivity of the airways.
Mannitol test
The mannitol test was performed according to the manu-
facturer’s instructions (Pharmaxis Ltd, French Forest, NSW,
Australia) [21]. In participants negative to EVH, the
mannitol challenge was stopped when a 15% decrease in
FEV1 was measured, or when a total cumulative dose of
635 mg had been administered. In those positive to EVH,
the mannitol challenge was stopped when the same fall in
FEV1 was attained as during the first visit (all but one
athlete had a 15% fall in FEV1 post-EVH and for the athlete
with a 14% fall in FEV1 post-EVH we aimed for a 15% in FEV1
during mannitol challenge), or when a total cumulative
dose of 635 mg had been administered. A test was consid-
ered positive when the fall in FEV1 was 15% from the 0 mg
dose. The response was expressed as the provoking dose of
mannitol required to induce a 15% fall in FEV1 (PD15), an
index of airway sensitivity. The responseedose ratio (RDR;
final percentage fall FEV1/total dose of mannitol adminis-
tered), an index of airway reactivity, was also calculated.
Following completion of the test, forced vital capacity
manoeuvres were performed at the same time intervals as
those after challenge with EVH. The best FEV1 value at each
time point was used in the analysis. During the recovery
period, FEV1 readings were compared to baseline to
calculate the % fall in FEV1.
Urinary CC16
Participants were asked to drink 200 mL of water 1 h before
arrival. At commencement of the study visits, participants
emptied their bladder and provided a baseline urine sam-
ple. Post bronchial provocation testing, urine samples were
collected at 30 and 60 min. After each urine collection,
200 mL of water was provided. All samples were stored
without addition of preservatives at minus 80 C and were
analysed within two months [22]. CC16 was measured using
the Human Clara Cell Protein ELISA kit from BioVendor
(Modrice, Czech Republic) according to the manufacturer’s
protocol. The detection limit for CC16 was 20 rg ml1. All
samples were analyzed for creatinine using a COBAS 6000
System analyser (Roche Diagnostics) to correct results for
dilution.
Atopic status
In eighteen athletes skin prick tests were carried out using
standardized allergen extract (ALK, Abello, UK) of house
dust mite, timothy grass and cat hair, together with a
positive and negative control. A reaction with a wheal of
3 mm in diameter was considered a positive test for
atopy. In the first six participants allergens extracts were
not available at the time of testing.
Data analysis
Sample size requirements were calculated using the data
from our previous study [2]; for an alpha of 5% and a beta of10%, it was expected that at least 21 participants would be
needed to detect a reduction of 60% in the rise in urinary
CC16 after mannitol compared to after EVH. Athletes were
grouped a posteriori as AHRþ (for those positive to EVH
and/or mannitol) or AHR (for those negative to both EVH
and mannitol). CC16 results are presented as peak versus
baseline, with the peak value as the highest value observed
at 30 or 60 min after bronchial provocation challenge. The
areas under the time curve (AUC) for CC16 and FEV1 were
calculated from the absolute and relative changes from
baseline respectively, during the 60-min observation period
after both challenges by using the trapezoidal method.
Between-group comparisons were carried out using un-
paired t-tests, Mann Whitney tests (for non-parametric
variables) or Fishers’ exact test (for binomial variables).
Urinary CC16 data were not normally distributed. There-
fore, within-group comparisons were carried out using
Friedman or Wilcoxon tests. Spearman’s rank correlation
test was used to check for relationships between study
variables. All statistical calculations were performed using
SPSS 15.0 for Windows (SPSS, Inc., Chicago, IL). Values are
means  SD, unless otherwise stated. The level of signifi-
cance was set at P < 0.05.
Results
Participant characteristics
Twelve participants trained in endurance sports, six in team
sports, two in combat sports, three in trampolining/aero-
bics, and one in rock climbing. Anthropometric, training
and baseline lung function data were similar between
athletes AHRþ and AHR (Table 1).
Airway response to EVH and mannitol
Eleven athletes (46%) were positive with a sustained 10%
fall after EVH. One athlete had a non-sustained broncho-
constriction (maximum fall in FEV1 of 10% at 10 min re-
covery only) and was classified as EVH negative. The fall in
FEV1 for the EVH positive group was 25  12% (versus 7  2%
in the EVH negative group, P < 0.001). The ventilation
achieved by athletes positive and negative to the test was
similar (96  15 versus 100  16 L min1) and was equiva-
lent to 78  6 and 81  10% pred. maximal voluntary
ventilation (calculated as 35 times baseline FEV1),
respectively.
Eight athletes (33%) were positive to mannitol with an
FEV1 fall of 21  13% (versus 4  3% in negative group,
P Z 0.001), a PD15 of 254  169 mg, and an RDR of
0.066  0.035%$mg1 (versus 0.005  0.007%$mg1 in the
negative group, PZ 0.002). Three athletes positive to EVH
did not reach the 15% threshold after inhaling 635 mg of
mannitol. A strong association was found between airway
reactivity to mannitol expressed as the RDR mannitol and
airway reactivity to dry air hyperpnoea expressed as % fall
in FEV1 post-EVH (rs Z 0.738, P < 0.001).
Within each study group (athletes AHRþ and AHR) the
maximal fall in FEV1 during the recovery period and FEV1-
AUC were similar between visits (data not shown). Out of
the fifteen athletes with current physician-diagnosed
Table 1 General characteristics of the study population.
All athletes AHRþ AHR
N (males) 24 (12) 11 (5) 13 (7)
Age (yr) 28  8 27  7 29  10
Height (cm) 172  9 170  9 175  9
Mass (kg) 73.8  12.6 74.2  15.5 73.4  10.1
Weekly training (h) 7  3 7  3 7  4
Training history (yr) 10  8 9  8 10  9
FEV1 (L) 3.54  0.57 3.54  0.58 3.54  0.59
FEV1 (% predicted) 95  11 98  12 93  10
FVC (L) 4.72  0.86 4.76  0.78 4.69  0.95
FVC (% predicted) 108  12 113  14 104  9
FEV1/FVC (%) 75  7 75  8 76  7
FEF25e75 (L s
1) 3.03  0.85 3.00  0.93 3.06  0.81
FEF25e75 (% predicted) 69  18 68  19 69  17
Physician diagnosis of asthma/EIB [N (%)] 17 (71%) 9 (82%) 8 (62%)
IBA use [N (%)] 10 (42%) 6 (55%) 4 (31%)
ICS use [N (%)] 5 (21%) 3 (27%) 2 (15%)
Atopy [Nþ/N total (%)] 12/18 (67%) 6/7 (86%) 6/11 (55%)
Values are means  SD or N (%). AHRþ, athletes with airway hyper-responsiveness to dry air and/or mannitol; AHR, athletes without
airway hyper-responsiveness to dry air and mannitol; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity;
FEF25e75, forced expiratory flow between 25 and 75% of FVC; EIB, exercise-induced bronchoconstriction; IBA, inhaled beta2-agonists;
ICS; inhaled corticosteroids; Nþ, number of athletes with atopy. Between-group comparisons were not statistically significant.
1840 P. Kippelen et al.asthma and/or EIB, eight (53%) did not have AHR (two of
whom were prescribed ICS). Two athletes with physician-
diagnosed childhood asthma were positive to EVH and
mannitol. Out of the five athletes using ICS daily for at least
6 months, three still had demonstrable AHR. Three out of
five athletes using inhaled SABA alone also still had
demonstrable AHR.Urinary CC16
Three participants AHR had urinary CC16 concentrations
below detection limits during both tests and were excluded
from the CC16 statistical analysis. Two participants AHRþ
had urinary CC16 concentrations below detection point
during one visit only (one during the EVH visit and one
during the placebo visit); their CC16 values during the
alternative visits were kept for analysis. Urinary CC16 data
at each time point and the magnitude of change post-
challenges did not significantly differ between AHRþ and
AHR athletes. Therefore all CC16 results are presented for
the study population as a whole.
Baseline urinary CC16 was similar between the two study
visits (Table 2). Both bronchial provocation tests caused an
increase in urinary excretion of CC16, as shown by the
statistically significant difference (P < 0.05) between the
peak CC16 concentration post-challenges and baseline
values (Fig. 1.). No significant difference in the magnitude
of change in urinary CC16 was observed between challenges
(Table 2). However, over the time-course of recovery, uri-
nary CC16 showed a significant increase both at 30 min
(P Z 0.003) and 60 min (P Z 0.006) post-EVH, whilst it
failed to reach significance after mannitol (Fig. 2). There
was also a trend for CC16-AUC to be greater after EVH
compared to mannitol (P Z 0.059) (Table 2).Significant correlations were found between CC16 values
after EVH and mannitol: for peak CC16 rs was 0.668
(PZ 0.002), for delta CC16 rs was 0.568 (PZ 0.011) and for
CC16eAUC rs was 0.556 (P Z 0.013). However, no signifi-
cant association was found between the maximal fall in
FEV1 post-challenges and the urinary release of CC16.
Furthermore, the release of CC16 post-mannitol did not
correlate with the total dose of mannitol inhaled.Discussion
The main aim of this study was to establish whether urinary
concentration of the pneumoprotein club cell CC16 was
increased after challenge with an osmotic stimulus in rec-
reational summer sports athletes with suspected EIB.
Inhaled mannitol was used because, like eucapnic voluntary
hyperpnoea, it has been used as a surrogate for exercise to
identify EIB [14]. The concentration of urinary CC16
increased after both EVH and mannitol bronchial provoca-
tion challenges. This suggests that hyperosmolarity of the
airway surface lining per se perturbs the functioning of the
airway epithelium in symptomatic athletes.
That dry air hyperpnoea leads to an increase in urinary
excretion of CC16 confirms our prior findings [2,17]. In one
study we demonstrated that breathing warm humid air
during exercise reduced, but did not completely inhibit the
increase in urinary CC16 post-exercise [2]. Those findings
suggested that, alongside mechanical stress, the thermal
and osmotic effects of evaporative water loss during
hyperpnoea also play a role in perturbing the airway
epithelium. We now extend these findings by reporting that
the osmotic challenge mannitol per se induces an increase
in urinary excretion of CC16. This differs from the urinary
CC16 data that were previously obtained post-mannitol in
Figure 1 Club cell (Clara cell) protein (CC16) measured in urine before and after eucapnic voluntary hyperpnoea (a) and
mannitol challenge (b) in recreational summer sports athletes with respiratory symptoms on exertion. ‘Peak’ are the highest values
recorded over the 60-min recovery period. Individual values with medians (interquartiles).
Table 2 Changes in airway calibre and in urinary club cell (Clara cell) protein 16 concentration after bronchial challenge with
eucapnic voluntary hyperpnoea (EVH) of dry air or mannitol in 24 symptomatic recreational summer sport athletes (11 with
airway hyper-responsiveness).
EVH Mannitol
FEV1 values
Maximal fall of FEV1, % 10 (7;27) 9 (6;26)
FEV1eAUC, %$min 339 (189;616) 238 (169;507)
Urinary CC16, rg mmol creatinine1
Baseline (pre-challenge) 113 (43;242) 87 (44;201)
30 min Post-challenge 239 (114;573)** 146 (72;275)
60 min Post-challenge 305 (80;666)** 186 (86;297)a
Peak post-challenge 305 (124;666)** 186 (100;342)*
Pre- to peak post-challenge (delta) 250 (39;435) 80 (4;198)
CC16eAUC, rg mmol creatinine1$min 6250 (1095;13211) 1860 (308;5528)b
Values are medians (inter-quartile ranges); FEV1, forced expiratory volume in the first second; AUC, area under the curve; CC16, club
cell (Clara cell) protein 16. Urinary CC16 did not significantly differ between athletes with and without airway hyper-responsiveness,
therefore data from both groups are presented together. *P < 0.05, **P < 0.01, significantly different from baseline.
a P Z 0.079 compared to baseline.
b P Z 0.059, compared to EVH.
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Figure 2 Mean  SEM urinary excretion of club cell (Clara cell) protein (CC16) in symptomatic recreational summer sports
athletes at baseline and over a 60-min period after eucapnic voluntary hyperpnoea (EVH) and mannitol challenge.
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an increase in urinary CC16 1 h after completion of a
swimming test, but not after mannitol. Alongside the
possible confounding effect of chlorination by-products on
CC16 data [5,16], differences such as age of the partici-
pants [23,24], level of competition and urine collection
times could have contributed to the divergence with our
current findings.
One limitation of our study is that the population was
heterogeneous in terms of medical history and pharmaco-
logical treatment. Whilst we acknowledge that asthma and
EIB are two distinct entities, EIB is highly prevalent in
asthmatic individuals [6]. Furthermore, all our participants
with a physician diagnosis of asthma reported exercise-
related respiratory symptoms, which are suggestive of
EIB. The diversity of medical history ensured that our
population was representative of the athletic population
that commonly consult primary care for respiratory disor-
ders, and allowed us to draw some conclusion about the
appropriateness of using mannitol to help with the diag-
nosis of asthma/EIB in recreational summer sports athletes.
In keeping with studies performed in elite summer sports
athletes (non-swimmers) [14] and in non-athletic mild
asthmatics [25], mannitol had a very high specificity (100%)
to detect a positive response to EVH. The sensitivity of
mannitol to identify those positive to EVH was however
lower (73%), which suggests that in recreational summer
sports athletes not engaged in competitive swimming
mannitol may be better used to rule-in (rather than to rule-
out) the presence of AHR to dry air. We cannot exclude that
the long-term use of ICS may have modified club cell
biology [26] and/or integrity of the airway epithelium [27].
Following removal in our statistical analysis of the five
steroid-treated participants, the significant increase in
urinary CC16 remained for both bronchial provocation
challenges. Therefore, it is unlikely that ICS usage
compromised our overall results.
In our study, the sequence of the challenges was inten-
tional to match the severity of bronchoconstriction for EVH
and mannitol, and to avoid differences in local shear de-
formations and pressure gradients through mucosalfolding [28]. This was critical in that the airway epithelium
is thought to play a prominent role in transducing me-
chanical stresses to nearby mesenchymal cells [29] and,
therefore, in activating mediator release [30]. Unfortu-
nately, we were not in a position to run an extra bronchial
provocation challenge with methacholine, which would
have helped to establish the role of airway narrowing per se
on epithelial perturbations in athletes.
That urinary CC16 increased after both challenges sug-
gests that, in addition to mechanical stress, an increase in
osmolarity is a contributing stimulus for CC16 changes
observed after EVH. There was no association between the
total dose of mannitol administered and the release of
urinary CC16 post-challenge, a finding that suggests that
sensitivity of the epithelium to the osmotic stimulus is more
important to CC16 release than is dose. CC16 is thought to
play a role in reducing inflammation of the airways [31].
Both EVH and mannitol are associated with the release of
inflammatory mediators [32e34]. For this reason we
believe that the increase in urinary CC16 post-challenges
was due, at least partly, to an inflammatory-mediated in-
crease in production/secretion of CC16 by the club cells.
Alternatively, the post-challenge increases in urinary CC16
may be explained by an increased leakage of the protein
into the bloodstream following permeability changes of the
airway epithelium [35]. Changes in ventilation pattern [36]
and pulmonary pressure [37] have been shown to increase
airway epithelial permeability. Moreover, in conditions of
airflow-related shear stress, injury and even death of
epithelial cells may occur [38]. During EVH, transient
airway epithelial injury could therefore have facilitated the
passage of CC16 from the airways to the bloodstream [17]
and contributed to the rise of CC16 in urine.
Many athletes routinely engage in sports associated with
high ventilatory demands, and often do so in cold dry en-
vironments. In these conditions, small airways are likely to
be exposed to inadequately conditioned air, which may
favour the release of inflammatory mediators of broncho-
constriction [39]. Furthermore, as club cells are mainly
localised in the distal airways [40], CC16 is more likely to be
released when small airways get dehydrated. The EVH test,
Urinary CC16 after bronchial challenge in athletes 1843which requires the use of a dry gas mixture and sets up a
high target ventilatory flow for the participants, is partic-
ularly well-suited to cause dehydration to the small air-
ways. Hyperpnoea with dry air has previously been shown
to reduce mucociliary clearance in both the proximal and
the peripheral airways [41]. Mannitol, however, is thought
to have greater effect on the osmolarity of the proximal
airways [42]. A regional difference in the dehydration stress
induced in our study may therefore have contributed to a
different level of stimulation of the club cells, and may
explain i) the lack of significant increase in CC16 at 30 and
60 min post-mannitol and ii) the trend for a greater CC16-
AUC after EVH compared to mannitol.
In elite endurance athletes the risk for asthma, AHR and
EIB is significantly increased [9]. Moreover, airway remod-
elling (a direct marker of injury-repair) has been observed
in elite cross-country skiers [43] and in elite swimmers [24].
It is therefore tempting to speculate that, similarly to the
‘chronic wound scenario’ proposed for the pathogenesis of
asthma in the general population [1], elite athletes expose
their airways to repeated mechanical, thermal and osmotic
stresses that cause disruption of the airway epithelium and
lead to structural and functional changes.
In conclusion, this study showed an increase in the
concentration of urinary CC16 both after EVH and mannitol
bronchial provocation challenges in recreational summer
sports athletes who report respiratory symptoms on exer-
tion. It is therefore likely that hyperosmolarity of airway
surface lining contributes to the increase in CC16 following
dry air hyperpnoea in symptomatic athletes. This
strengthens the viewpoint that osmotic changes associated
with the conditioning of large volumes of air during stren-
uous exercise can cause damage to the airway epithelium
[10].
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